- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07571668
Effects of Robotic Hand Therapy on Hand Function and Dexterity in Cerebral Palsy
Effects of Robotic Hand Therapy in Comparison to Conventional Therapy on Hand Function and Dexterity in Children With Hemiplegic Cerebral Palsy; a Randomized Controlled Trial
This randomized controlled trial aims to evaluate the effects of robotic hand therapy using the Syrebo E12 soft-robotic glove compared with conventional physiotherapy on hand function and manual dexterity in children with hemiplegic cerebral palsy. Children aged 7-15 years, classified as GMFCS I-III and MACS I-III, will be recruited from multiple rehabilitation centers in Pakistan. Participants will be randomly allocated (1:1) to either robotic therapy or standard physiotherapy, receiving 45-minute sessions, three times per week for 8 weeks.
The primary outcome is functional hand performance measured by the Jebsen-Taylor Hand Function Test (JTHFT). Secondary outcomes include ABILHAND-Kids, Box and Block Test, Nine-Hole Peg Test, grip strength, and qualitative feedback. Assessments will occur at baseline, week 4, week 8, and at a 6-month follow-up. A mixed-effects repeated-measures ANCOVA will be used for analysis following the intention-to-treat principle.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Qamar Mehmood, Ph.D.
- Numéro de téléphone: +923335151063
- E-mail: qamar.mehmood@riphah.edu.pk
Lieux d'étude
-
-
-
Islamabad, Pakistan
- Riphah International University
-
Contact:
- Mudassar Ali, Ph.D*
- Numéro de téléphone: +923015255090
- E-mail: mudassarpt@gmail.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
Accepte les volontaires sains
La description
Inclusion Criteria:
- Patients diagnosed with Hemiplegic type of Cerebral palsy
- Age 7 to 15 years
- Ability to understand and follow simple instructions
- Gross Motor Function Classification System (GMFCS) levels I-III (ambulatory)
- Manual Ability Classification system (MACS) I to III
- Stable medical condition (no major changes in medication or therapy in the past 3 months).
Exclusion Criteria:
- Patients with severe cognitive dysfunction.
- Fixed contractures or deformities of the upper limb that would prevent safe use of the robotic device.
- Recent upper limb surgery, botulinum toxin injection, or casting within the past 6 months.
- Uncontrolled epilepsy or other unstable medical conditions.
- Visual or auditory impairments that would interfere with assessment or therapy.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Physiothérapie conventionnelle
|
Participants in this group will receive conventional physical therapy based on neurodevelopmental and task-oriented principles, including stretching, strengthening, sensory re-education, and functional hand-use training.
Sessions will last 45 minutes, three times per week for six weeks, delivered by a licensed physical therapist following a standardized treatment checklist.
The program targets improvements in hand strength, dexterity, range of motion, and fine motor skills, with safety and treatment fidelity monitored throughout.
|
|
Expérimental: Robotic Hand Therapy
|
Participants in this group will receive robotic hand therapy using a glove-based robotic rehabilitation device that provides passive, active-assisted, and resistive training to facilitate repetitive, task-specific hand movements.
Each 45-minute session will be delivered three times per week for six weeks under therapist supervision, focusing on improving grasp-release patterns, finger mobility, and functional hand use.
Therapy intensity will be progressively adjusted based on performance and tolerance, and all sessions will be monitored for safety and adverse events.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Jebsen-Taylor Hand Function Test
Délai: 8 Weeks
|
Jebsen-Taylor Hand Function Test (JTHFT) will objectively quantify functional capacity of hand.
|
8 Weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
ABILHAND-Kids
Délai: 8 Weeks
|
ABILHAND-Kids for perceived manual ability in daily activities (Subjective assessment).
|
8 Weeks
|
|
Box and Block Test
Délai: 8 Weeks
|
Box and Block Test [BBT] for unilateral gross manual dexterity
|
8 Weeks
|
|
Nine-Hole Peg Test (NHPT)
Délai: 8 weeks
|
Nine-Hole Peg Test (NHPT) fine finger dexterity (time to place and remove pegs)
|
8 weeks
|
|
o'connor test
Délai: 8 Weeks
|
The O'Connor Finger Dexterity Test is a, standardized, timed, aptitude assessment designed to measure fine motor skills and rapid, precise manipulation of small objects.
It is widely used in vocational testing, industrial hiring (assembly line work), and clinical rehab to evaluate finger dexterity by placing three pins into 100 holes.
|
8 Weeks
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Qamar Mehmood, Ph.D., Riphah International University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- RCRAHS-ISB/REC/PhD/011110
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .